Pain Management

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

An exit strategy for opioid therapy

January 26, 2012

What exit strategy do you recommend for discontinuing opioid therapy?
 

Work-around: An indirect way to accomplish the same goal

December 19, 2011

Interpersonal relations are comparable to navigating computer software. A change in approach may produce the desired results.
 

Exploring holistic medicine: Using acupuncture to relieve cancer-related fatigue

December 19, 2011

The ancient Eastern medicinal art can relieve one of the most distressing effects of cancer and cancer treatment: fatigue.
 

Oncologists need to sharpen their pain-management skills

Delicia Honen Yard November 25, 2011

The results of a recent survey suggest that pain-related knowledge and practice may not be up to par within the oncology community.
 

Vitamin D regimen is effective in resolving bone pain related to aromatase-inhibitor therapy

October 19, 2011

High-dose vitamin D may relieve, even resolve, severe pain in patients on aromatase inhibitor therapy for breast cancer.
 

Guidelines reflect changes in radiotherapy for bone metastases

October 19, 2011

New ASTRO guidelines for palliative radiotherapy for bone metastases reflect the results of a meta-analysis of 45 studies.
 

Methylnaltrexone (Relistor)

October 19, 2011

Methylnaltrexone is a peripheral acting narcotic antagonist, opioid reversing agent. It is indicated for treatment of opioid-induced constipation.
 

After breast cancer, fatigue plagues women who are depressed and in pain

Delicia Honen Yard October 05, 2011

Women most affected by fatigue following treatment for breast cancer also suffer episodes of depression and body-image deterioration, neck and shoulder pain, and limited arm movement
 

CIPN: Treatment preservation and prevention are the goals

Colleen H. Erb, MSN, ACNP-BC, AOCNP September 21, 2011

CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.
 

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

Visit Reflections for first-hand stories on the power of the patient to impact caregivers in oncology nursing.
Like to share a comment on our new site or another topic of interest to you? Click here and start typing.
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions